Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2010.32.8112 on April 4 2011

Journal of Clinical Oncology, Vol 29, No 16 (June 1), 2011: pp. 2185-2190
© 2011 American Society of Clinical Oncology.

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tosoian, J. J.
Right arrow Articles by Carter, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosoian, J. J.
Right arrow Articles by Carter, H. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Delicious   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJ OpenHome page
Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study
BMJ Open, February 17, 2016; 6(2): e010191 - e010191.



Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Zhu, Z. Liu, J. I. Epstein, C. Davis, C. S. Christudass, H. B. Carter, P. Landis, H. Zhang, J.-Y. Chung, S. M. Hewitt, et al.
A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype
Cancer Epidemiol. Biomarkers Prev., December 1, 2015; 24(12): 1864 - 1872.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
J. A. Roth, S. D. Ramsey, and J. J. Carlson
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer
Oncologist, December 1, 2015; 20(12): 1355 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Journal of Clinical UrologyHome page
M. Hadjipavlou, J. Promponas, and S. Madaan
Active surveillance for low-risk prostate cancer
Journal of Clinical Urology, November 1, 2015; 8(6): 420 - 428.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. C. Koo, S. U. Park, K. H. Rha, S. J. Hong, S. C. Yang, C. H. Hong, and B. H. Chung
Transurethral resection of the prostate for patients with Gleason score 6 prostate cancer and symptomatic prostatic enlargement: a risk-adaptive strategy for the era of active surveillance
Jpn. J. Clin. Oncol., August 1, 2015; 45(8): 785 - 790.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. R. Cooperberg
Long-Term Active Surveillance for Prostate Cancer: Answers and Questions
J. Clin. Oncol., January 20, 2015; 33(3): 238 - 240.
[Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
A. A. Aizer, X. Gu, M.-H. Chen, T. K. Choueiri, N. E. Martin, J. A. Efstathiou, A. S. Hyatt, P. L. Graham, Q.-D. Trinh, J. C. Hu, et al.
Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States
J Natl Compr Canc Netw, January 1, 2015; 13(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
X. Wang, J. Chen, Q. K. Li, S. B. Peskoe, B. Zhang, C. Choi, E. A. Platz, and H. Zhang
Overexpression of {alpha} (1,6) fucosyltransferase associated with aggressive prostate cancer
Glycobiology, October 1, 2014; 24(10): 935 - 944.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
J. L. Mohler, P. W. Kantoff, A. J. Armstrong, R. R. Bahnson, M. Cohen, A. V. DAmico, J. A. Eastham, C. A. Enke, T. A. Farrington, C. S. Higano, et al.
Prostate Cancer, Version 2.2014
J Natl Compr Canc Netw, May 1, 2014; 12(5): 686 - 718.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. J. Wilt, P. T. Scardino, S. V. Carlsson, and E. Basch
Prostate-Specific Antigen Screening in Prostate Cancer: Perspectives on the Evidence
J Natl Cancer Inst, March 4, 2014; (2014) dju010v1.
[Full Text] [PDF]


Home page
J Oncol PractHome page
A. A. Aizer, J. J. Paly, M. D. Michaelson, S. K. Rao, P. L. Nguyen, I. D. Kaplan, A. Niemierko, A. F. Olumi, and J. A. Efstathiou
Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer
J. Oncol. Pract, March 1, 2014; 10(2): 107 - 112.
[Abstract] [Full Text] [PDF]


Home page
Journal of Clinical UrologyHome page
S. Segaran, J. Jelski, and N. Burns-Cox
Active surveillance: a cautionary tale
Journal of Clinical Urology, March 1, 2014; 7(2): 112 - 115.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
A. A. Aizer, J. J. Paly, A. L. Zietman, P. L. Nguyen, C. J. Beard, S. K. Rao, I. D. Kaplan, A. Niemierko, M. S. Hirsch, C.-L. Wu, et al.
Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer
J Natl Compr Canc Netw, November 1, 2013; 11(11): 1364 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Sci Transl MedHome page
S. Irshad, M. Bansal, M. Castillo-Martin, T. Zheng, A. Aytes, S. Wenske, C. Le Magnen, P. Guarnieri, P. Sumazin, M. C. Benson, et al.
A Molecular Signature Predictive of Indolent Prostate Cancer
Science Translational Medicine, September 11, 2013; 5(202): 202ra122 - 202ra122.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
D. H. Lee, K. C. Koo, S. H. Lee, K. H. Rha, Y. D. Choi, S. J. Hong, and B. H. Chung
Low-risk Prostate Cancer Patients Without Visible Tumor (T1c) On Multiparametric MRI Could Qualify for Active Surveillance Candidate Even If They Did Not Meet Inclusion Criteria of Active Surveillance Protocol
Jpn. J. Clin. Oncol., May 1, 2013; 43(5): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. W. Lin, L. F. Newcomb, E. C. Brown, J. D. Brooks, P. R. Carroll, Z. Feng, M. E. Gleave, R. S. Lance, M. G. Sanda, I. M. Thompson, et al.
Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
Clin. Cancer Res., May 1, 2013; 19(9): 2442 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
S. D. Fung-Kee-Fung, S. P. Porten, M. V. Meng, and M. Kuettel
The Role of Active Surveillance in the Management of Prostate Cancer
J Natl Compr Canc Netw, February 1, 2013; 11(2): 183 - 187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Sowalsky, H. Ye, G. J. Bubley, and S. P. Balk
Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4
Cancer Res., February 1, 2013; 73(3): 1050 - 1055.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. J. Roobol, C. H. Bangma, and S. Loeb
Prostate-specific antigen screening can be beneficial to younger and at-risk men
Can. Med. Assoc. J., January 8, 2013; 185(1): 47 - 51.
[Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
R. M. Hoffman
Improving the Communication of Benefits and Harms of Treatment Strategies: Decision Aids for Localized Prostate Cancer Treatment Decisions
J Natl Cancer Inst Monographs, December 1, 2012; 2012(45): 197 - 201.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
G. S. Sandhu and G. L. Andriole
Overdiagnosis of Prostate Cancer
J Natl Cancer Inst Monographs, December 1, 2012; 2012(45): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
A. S. Glass, M. R. Cooperberg, M. V. Meng, and P. R. Carroll
Role of Active Surveillance in the Management of Localized Prostate Cancer
J Natl Cancer Inst Monographs, December 1, 2012; 2012(45): 202 - 206.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
H. B. Carter
Active Surveillance for Prostate Cancer: An Underutilized Opportunity for Reducing Harm
J Natl Cancer Inst Monographs, December 1, 2012; 2012(45): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
D. H. Lee, H. B. Jung, S. H. Lee, K. H. Rha, Y. D. Choi, S. J. Hong, S. C. Yang, and B. H. Chung
Comparison of Pathological Outcomes of Active Surveillance Candidates Who Underwent Radical Prostatectomy Using Contemporary Protocols at a High-volume Korean Center
Jpn. J. Clin. Oncol., November 1, 2012; 42(11): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Burton, R. M. Martin, J. L. Donovan, J. A. Lane, M. Davis, F. C. Hamdy, D. E. Neal, and K. Tilling
Associations of Lifestyle Factors and Anthropometric Measures with Repeat PSA Levels During Active Surveillance/Monitoring
Cancer Epidemiol. Biomarkers Prev., October 1, 2012; 21(10): 1877 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Xia, B. J. Trock, M. R. Cooperberg, R. Gulati, S. B. Zeliadt, J. L. Gore, D. W. Lin, P. R. Carroll, H. B. Carter, and R. Etzioni
Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy
Clin. Cancer Res., October 1, 2012; 18(19): 5471 - 5478.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
D. D. Buethe and J. Pow-Sang
Enrollment Criteria Controversies for Active Surveillance and Triggers for Conversion to Treatment in Prostate Cancer
J Natl Compr Canc Netw, September 1, 2012; 10(9): 1101 - 1110.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. A. Aizer, J. J. Paly, A. L. Zietman, P. L. Nguyen, C. J. Beard, S. K. Rao, I. D. Kaplan, A. Niemierko, M. S. Hirsch, C.-L. Wu, et al.
Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer
J. Clin. Oncol., September 1, 2012; 30(25): 3071 - 3076.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
J. L. Mohler
Ten Years of Progress in Prostate Cancer
J Natl Compr Canc Netw, February 1, 2012; 10(2): 136 - 140.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. G. Nelson
Profiling prostate cancer
PNAS, December 27, 2011; 108(52): 20861 - 20862.
[Full Text] [PDF]


Home page
JCOHome page
M. R. Cooperberg, P. R. Carroll, and L. Klotz
Active Surveillance for Prostate Cancer: Progress and Promise
J. Clin. Oncol., September 20, 2011; 29(27): 3669 - 3676.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tosoian, J. J.
Right arrow Articles by Carter, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosoian, J. J.
Right arrow Articles by Carter, H. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Delicious   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2011 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online